Brown & Brown (BRO) › Analysis

Brown & Brown (BRO) stock analysis, November 3, 2026: Uptrend intact, but breakout math falls short of 3-to-1

Published November 3, 2026 · BRO chart, levels and live analysis

Brown & Brown, Inc. (BRO) trades at $70.62 after a 4.8% five-day gain that beat both a falling market and the financial sector, even though shares slipped 1.75% today. Third-quarter revenue rose 7.4%, but organic growth was only 1.2%, and the stock sits 5.2% below its October 22 peak. The balance of evidence leans positive with high conviction: the daily trend runs with the weekly uptrend, and BRO is leading both the S&P 500 and XLF.

Why it matters

The event that set the tone was the third-quarter report on October 26, 2026. Revenue came in at $1.73 billion, up 7%, and net income was $240.0 million, up 6%, according to the 10-Q filing. Diluted earnings per share were $0.67, down about 1% from a year earlier. The company's earnings release put organic revenue growth at 1.2%, or 1.5% with contingent commissions. So most of the top-line growth came from acquisitions rather than from the existing book. That mix matters for an insurance broker valued on steady internal growth.

Much of the good news was already in the price. The stock gained 18.1% over the past month and peaked at $74.49 on October 22, four days before the report. It is now $70.62, 5.2% below that close. The numbers did not extend the run, and the pullback looks like a market digesting a big advance rather than reacting to a bad quarter. An October 22 8-K under Item 5.02 reported a director or officer change, but the filing as provided gives no detail on who or why. It cannot be tied to the move.

On the last five days, the market was a headwind and the sector a tailwind. The S&P 500 (SPY) fell 2.06% and XLF rose 2.34%, while BRO gained 4.77%, which is 2.4 points more than its sector. So the stock's own strength accounts for a modest slice of the gain and the sector rotation for most of it. No news item explains the stock's extra 2.4 points. Today's 1.75% decline came while SPY rose 0.23% and XLF fell 0.65%. The sector explains a fraction of it, and nothing in the news explains the rest. Volume is running about 45% below its 20-day average, which suggests the dip lacks urgency.

No published debate about BRO appears in the sources provided, so the two sides come from the numbers. The positive case is 7.4% revenue growth, 6% net income growth and a stock still leading its sector. The cautious case is that organic growth of 1.2% is thin and per-share earnings fell. The 18 analysts covering the stock sit between the two, with a consensus of hold and a mean price target of $74.39, in a range from $55 to $85. At $70.62 the shares trade 5.1% below that mean, so the stock is not stretched against its analysts, though it offers no large discount either.

What the evidence says

The long-term thesis is intact but still repairing. The price is above its 40-week average, and the 50-day average at $66.91 sits just above the 200-day at $66.54. The stock is up 22.8% over six months but still down 11.2% year to date and 14.2% below its 52-week high of $82.33. That points to a recovery inside a larger drawdown, not a fresh, unobstructed advance. The 52-week low of $54.38 is 29.9% below the current price, so the damage has largely been undone, but the old high is a long way up.

For the next 2 to 6 weeks, the balance of evidence leans positive, and conviction is high at 3 of 4 points. The daily trend runs with the weekly uptrend. BRO is leading the S&P 500 over 50 days by 7.4% and XLF by 3.3%. The RSI of 60.9 shows momentum without an overbought stretch. The trend is also aligned across timeframes, which is the kind of agreement that tends to make pullbacks shallow.

The strongest case against is that the stock has already slipped 5.2% from its peak, fell again today, and has a consensus rating of only hold. Organic growth of 1.2% gives the fundamentals little to build on, and a 14% gap to the 52-week high means overhead supply is heavy. That is why the evidence is not unanimous at 4 of 4. It does not tip the balance because the trend structure, the relative strength against both benchmarks and the position above the 50-day average are all intact.

Levels that matter

The structure holds above $70.00, a round number just under the current price, and the first crack comes on a break below it. Beneath that sits a swing zone at $68.96. The trend ends below $66.91, the 50-day average, with the 200-day at $66.54 right beside it. Those two averages form a floor that has contained the recovery, which is why a break through both would matter far more than a dip under $70.

The breakout level is a daily close above $73.90 on volume above its 20-day average. Today's thin volume shows the stock has not yet had that kind of participation. From there the first target is $75.14 and the second is $76.98. The math uses a stop at $69.36, which is $70.00 minus a quarter of the 14-day ATR of $2.58. Against that stop the targets give only 0.3 to 1 and 0.7 to 1. The math does not reach 3 to 1. It would take a target beyond the 52-week high of $82.33, or a much tighter stop, to change that. The next resistance after $76.98 is the round $80.00, and even that sits too close to reach 3 to 1 from a $73.90 entry.

What would change the picture

The rule is a weekly close below $66.91, the 50-day average. That would put the price under the level that has anchored the recovery and leave the 200-day average as the last nearby support. The one non-price fact that would do the same is organic revenue growth slipping below the 1.2% reported for the third quarter. That would show the acquisition-led growth is not being matched by the existing book.

What to watch

Get a message when the BRO picture changes — the agent team watches the levels and the news for you.Create a free account

More BRO analyses

Research & education, not advice. MarketCrew is AI-powered and can make mistakes.